µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º [S6u:;7
E ,i^rA m
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ e@3SF
M;A_'h?Z
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) f)sy-o!
f&-`+V}U
1. ICAM-1 1}VaBsEV
F^l1WX6
2. interleukin 12(IL-12)
>a"J);p
EjP;P}_i
K
3. tumor infiltrating lymphocyte [6VB&
TXImmkC
4. TCR/CD3 complex \M`qaFan5^
zTng]Mvx
5. hematopoietin receptor family [ycX)iM
7Kw'Y8
6. individual idiotype(IdI) L;V8c
Q<sqlh!h
7. integrin }aWy#Oe
[8QK @5[
8. colony-stimulatory factor (CSF) p]aEC+q
'z}
t= ?
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© $
N?8[
"#C2+S
KM1
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? cSt)Na~C
<+QdBp'd;
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ TgkVd]4%
k9k39`t
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷ÓᣠYjoe|
?L<B]!9HZt
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ tpWGmjfo>
aUw-P{zp%
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) ,YD7p= PY
2^r~->
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ 2cCiHEL #
*OLqr/ yb
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) ]-gyXE1.r
0pE>O
7
3. immunoglobulin superfamily (IgSF) +byOThuE
]dUG=dWO
4. selectin K6DN>0sY
TUfj\d,
5. anti-idiotypic antibody (¦ÁId) hl1IG
!
sh
:$J[
6. major histocompatibility complex(MHC) V,-we|"
ed6@o4D/kf
7. immunotolerance OjGI
!
AR[m+E
8. biological reponse modifier(BRM) E0ED[d,
}a;xs};X;
9. immune reponse gene (Ir gene) ]$/oSa/
*qzdt^[ xo
10. reshaped antibody (or reconstituted antibody) 1G
YZ1iA
t'U=K>7
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© 3L&:
)Q1>j 2&
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ ^`cv6;)
}5+^
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? .lcp5D[(
5_(\Cd<#
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ CV0id&Nv
Y
D<3#Dr]
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? a&'9[9E1
]^ R':YE
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ KZ 5%q.
':n`0+Eh
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? %Xh}{ o$G
}2]|*?1,
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ ~:Rbd9IB
FtTq*[a
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ rn-bfzoDS
~9]vd|
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? j-9)Sijj{
)^(gwE
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ jG1(Oe;#
8c) eaDu
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: as@8L|i*
?-j/X6(\(
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: f7*Qa!!2p]
c+ZOC8R
̉񧄤 20}HTV{v
^;F/^_
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 8-<F4^i_i
uUjjAGZ
1. CD8 2q[pOT'k
+JI,6)Ry
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) J!om"h
~Z5AIm R|
3. immunoglobulin fold(Ig fold) |pHlBzHj
-1dD~S$
4. cadherin (Ca-dependent cell adhesion moleculers) Zv}F?4T~:
N7s0Ua'-v
5. idiotype-anti-idiotypic antibody immune network theory - ;gQy[U
LZ)g&A(j?
6. HLA class II antigen Il&FC
#;8)UNc)}
7. complementarity-determining region (CDR) 4
Y=0>FlY0
C
r R/
8. perforin(or pore-forming protein ,PFP) !BVCuuM>w
Y-})/zFc
9. high affinity IL-2 receptor uQ3sRJi
pmP~1=3
10. artificial active immunization '|gsmO
&/[MWQ
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© B=*0
<%.%
q
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óᣠ(LsVd2AbR
c9c]1XJ
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 zx<t{e7
@MibKj>o
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ Zsapu1HoL\
7Wef[N\x
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ ~ ?nn(Q-
=xkaF)AW&v
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ PI L)(%X
`=;}I@]zj)
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? w &YUb,{Y
#NyO'
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ B tznms'
M>=@Z*u/+
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ j8M t"B
+h-% {
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ 9q0s
a
7v^o`
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ .qe+"$K'n
,l!>+@
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© +D
@B eQu
EyR/
1. immunoglobulin gene rearrangement hwk] ;6[
P_jav0j7g
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) ^+%bh/2_W
=M:Po0?0E
3. flow cytometry(FCM) LTBH/[q5
QpzdlB44l
4. carrier effect 7Z+Fjy-B
Msvs98LvW
5. positive selection of T lymphocytes in thymus k ]gPMhe
Ax|'uvVAPT
6. mouse TH1(Th1) and TH2(Th2) subsets **-rPonM[
dVq9'{[3
7. perforin (pore-forming protein ,PFP) q%bFR[p<*
8S#&XS>o
8. ADCC(antibody-dependent cell-mediated cytotoxicity) V4u4{wU]
g_PP9S_?
9. SH-2(src-homology region 2) vp&.
D:K"J><@
10. Ab2¦Â (internal image) 8T+o.w==
bCTN^
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© *EO*Gg0d
N? S;v&q+
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? .|DrXJ\c
Y]~-S
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? lZkJ<*z#
r1.
zURY
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦Óᣠ3GL?&(eU;
O.Te"=^"F
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ r4K_Wp
FwKY;^`!d
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦Óᣠpi70^`@ 'B
| Wj=%Ol%o
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) X16O9qsh
s7jNRY V
ÃâÒßѧרҵ£º st.{AEv@
2u0B=0x
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ AL&<SxuP
jL)Y'
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? ;X+.Ag
uARkf'
´«È¾²¡Ñ§×¨Òµ£º SY.koW
0%|)=T3Slu
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ 4y4r;[@U
k^KpQ&n
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ D;48VK/Q
T1?9E{bC8A
Ïû»¯×¨Òµ£º @^#
9N!Fj]
5yJ~ q
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ ^%6f%]_
VgY6M_V
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? lA6{TH.x
;Hp78!#,
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ 5,O:"3>c
{~#01p5
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© @QYCoEU8J
E+ XR[p
1. Fas(CD95)/FasL XCgC^c'
8A*tpMV?J
2. common chain of cytokine receptor "}[ ]R
1b7?6CqV
3 . TCR/CD3 complex =:TQ_>$Nc2
U`{ M1@$
4. negaive selection of thymocytes 6aAN8wO;b
3EA_-?
5. artificial active immune %X\Rfn0J"
`sv]/8RN
6. anti-idiotypic @P=n{-pIW
xo-{N[r
7. IgSF i!<(R$Lo
Jcp=<z*0
8. Integrin -O@/S9]S)
q #8z%/~k
9. chemokine J3r':I}\
5a&gdqg]
10. B7/CD28 _JKz5hSl
kWbY&]ZO
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© n@oSLo`k,`
MGo`j:0
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ +xr;X 9
#yCnM]cEn
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ 9q^7%b,
1u*
(=!
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ \qJ^
n %
OJ7y
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£ AUaupNN
JgldC[|7
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ (g tOYEqx
(Q|Y*yI
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ J =#9eW
$bk_%R}s
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© .n}k,da@(
*MN("<A_
1. B7/CD28 lF$$~
G
;FjI!V
2. Th1 subset w6l56CB`
DEenvS`,P
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© ;:Y/"5h
,\PTn7_
4. antibody affinity maturation ~A>-tn}O
@N\
Ht'f
5. AP-1 Sr6?^>A@t
U9//m=_
6. single chain variable fragment£¨ScFv£© 0h"uJco,
p/jAr+XM
7. NK cell receptor i,$n4
*zDL5
9
8. Zinkernagel-Doherty phenomenon S%w67sGl4n
aDX4}`u
9. Ig fold <kWNx.eci
%VgK::)r
10. CD40/CD40L ;:ocU?
D+Z,;XZ
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© boIFN;Aq"
<``krPi
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£ Qkg([q4
)$E'2|Gm/
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ ltmD=-]G_
d>1#|
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ M0uC0\'#P
Z-z(SKL
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ [{rne2sA
N+ ei)-
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ ]4&B*]j
coc:$Sr%
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ 1
s#GY<<
SCD;(I~4
3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£ I$Fr8R$
'5SO3/{b
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£© U\", !S~<
ju;Myi}a
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© fn\&%`U
A/*h[N+2!
1.Co-stimulators (or co-stimulating molecules) ^]?Yd )v
Q02:qn?T
2.NK-kB -*&C
"%e
3 p9LVa
3.Immunoglobulin superfamily 3ocRq
%%K
2HJG
p+H
4.antigen-presenting cell (APC) uB uwE6
FuZLE%gP
5.death domain vD4<G{
I45\xP4i
6.CCR and CXCR p`LPO
&T/}|3S
7.Lectin (or mitogen) r$.v"Wh)
;X2 (G
8.Clusters of differentiation, CD) /w*;|4~Bf
) _O6_
9.B7 family 2wG4"
* E3
c--
10.Cytotoxic T lymphocyte, CTL) 6J%+pt[tu
Z
]WA-Q6n
11.IL-15 and IL-15 receptor (IL-15R) p~THliwd
g?caE)
12.MHC restriction xd`!z`X!,s
~h*p A8^L
13.Affinity-chromatography *!y.!v*
\3@A C7
14.Cyctosprin A, CsA Qvd$fY**
6|D,`dk3U
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) s GP}>w-JZ
~|~j01#
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© KGm"-W
yxa~Rz/
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 5Cs
JghTw
H19CVc\B
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ k(;c<Z{?1
d>Z{TFY
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ ~=,|dGAa$
'?~k`zK
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© [T.BK:
-'|pt,)
ÃâÒßѧרҵ£º $bU|'}QR
w^&TG3m1~
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ iM Xl}3
kE".v|@
Ïû»¯ÄÚ¿Æ£º 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ snBC +`-
{O,Cc$_
ѪҺ²¡Ñ§×¨Òµ£º 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿ jz$)*Kdi*
"l&sDh%Lk<
Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ (רҵ»ù´¡: ÃâÒßѧ) x=qACoq
%&"_=Lc
Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö) iw(\]tMt
qb
^4G
1. ADCC(antibody dependent cell-mediated cytotoxicity) X!n-nms
9b !+kJD
2. »·æß¾úËØ(cyclosporin) (iK0T.
C<6IiF[>%
3. KIR(killer cell inhibitory receptor) m4nJ9<-
1GW=QbO 6
4. HLDA(human leucocyte differentiation antigen) t9PS5O ;
dox QS ohS
5. Interleukin 18(IL-18) }d)>pH
]P ->xJ
6. ÕûºÏËØ(integrin) (G"b)"Qum
/
GJ"##<
7. Fas/FasL oa`,|dA"
;2}0Hr'|
8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå) '&3Sl?E
5in6Y5c kj
9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM) P7E}^y`e
-2tX 15,
10. Th1/Th2 {:Z# 8dGe
7s5?^^
11. »ùÒòÒßÃç(DNAÒßÃç) ix]3t^
FWdSpaas Q
12. chemokines and chemokine receptor r,MgIv(L
#0L:h?L
13. ÃâÒßÄÍÊÜ u3 ?+Hu|*T
Z[AJat@H
14. ¹²´Ì¼¤·Ö×Ó J(M0t~RZ
IVkKmO(qO
15. ËÀÍö½á¹¹Óò(death domain) rem&F'x0V
kzns:-a
¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö) UY{
Uo@k9x
Fm,A<+l@u
1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬? .rG Rdb
D/{Tl
2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦ÓᣠtJ.LPgfZ
xHykU;p@
£¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î 0'BR Sa<
ui G7
£¨2£©1977Ä꣺·ÅÉäÃâÒß·¨ RURO0`^
5:CC\!&QBV
£¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå $NG}YOP)@
Xj+1]KRN
£¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹ 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£ +#1WOQfAD
9eGM6qW\_
Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ) ÎÊ´ðÌâ(ÿÌâ25·Ö) IOTHk+
w
1.yw\ZC\
1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£ :
[aUpX=
z ;y22
2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿ Q`AJR$L
:;{U2q+
3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£ 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£